Nicotine e-cigarettes are more effective in helping people quit smoking than many conventional methods such as nicotine gums and patches and quitting with behavioral support or no support at all, an updated Cochrane review finds.

Until recently, the thymus was thought to be of little use beyond puberty, but new research has shown that radiation to the organ is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC). In a study published today in the leading cancer journal Annals of Oncology, researchers analyzed 1,107 patients with NSCLC and found that patients whose thymus was exposed to radiation during cancer treatment had an increased risk of the cancer spreading to other parts of the body (metastasizing) and of dying from their disease. This association was seen only in patients whose thymus was still relatively healthy before treatment.

Building on recent discoveries about the adult thymus, Mass General Brigham investigators used artificial intelligence to show that incidental radiation exposure to the thymus may influence outcomes in patients with lung cancer

A project led by Rice University’s Rice360 Institute for Global Health Technologies aimed at making breast cancer diagnosis faster and more accessible in rural and medically underserved communities across Texas has received support from the Hill Prizes program.

USC researchers have received two National Institutes of Health grants totaling $7.5 million to investigate whether exposure to per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” may increase the risk of liver and endometrial cancers. The studies will examine pre-diagnostic blood samples and laboratory models to identify how PFAS may contribute to cancer development and to explore how factors such as neighborhood, income and food access may influence exposure and risk.

PHILADELPHIA, PA – Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate risk prostate cancer indicate that the use of SBRT improved bowel health related quality of life (HRQOL) in this patient population. There was no significant improvement for SBRT seen for the other primary objectives including urinary HRQOL and disease-free survival. These results are now published in the Journal of the American Medical Association (JAMA) following the presentation during the Plenary Session of the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco, California.

Story-based testing reveals undetected memory difficulties in breast cancer survivors.